Skandinaviska Enskilda Banken AB publ Purchases 572 Shares of CME Group Inc. (NASDAQ:CME)

Skandinaviska Enskilda Banken AB publ boosted its position in CME Group Inc. (NASDAQ:CMEFree Report) by 0.8% in the second quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 72,718 shares of the financial services provider’s stock after purchasing an additional 572 shares during the quarter. Skandinaviska Enskilda Banken AB publ’s holdings in CME Group were worth $14,293,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in the company. B. Riley Wealth Advisors Inc. raised its holdings in CME Group by 1.3% in the fourth quarter. B. Riley Wealth Advisors Inc. now owns 3,625 shares of the financial services provider’s stock worth $782,000 after purchasing an additional 48 shares in the last quarter. Capital Advisors Ltd. LLC grew its stake in shares of CME Group by 4.3% during the first quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock worth $250,000 after acquiring an additional 48 shares during the last quarter. Lantz Financial LLC grew its stake in shares of CME Group by 1.1% during the first quarter. Lantz Financial LLC now owns 4,561 shares of the financial services provider’s stock worth $982,000 after acquiring an additional 49 shares during the last quarter. Lester Murray Antman dba SimplyRich grew its stake in shares of CME Group by 0.7% during the second quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock worth $1,507,000 after acquiring an additional 50 shares during the last quarter. Finally, Greystone Financial Group LLC grew its stake in shares of CME Group by 1.6% during the fourth quarter. Greystone Financial Group LLC now owns 3,282 shares of the financial services provider’s stock worth $691,000 after acquiring an additional 52 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The sale was disclosed in a filing with the SEC, which is available at this link. In other news, Director Bryan T. Durkin sold 7,593 shares of the company’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The sale was disclosed in a filing with the SEC, which is available at this link. Also, CFO Lynne Fitzpatrick sold 754 shares of the company’s stock in a transaction that occurred on Sunday, September 15th. The stock was sold at an average price of $216.99, for a total value of $163,610.46. Following the transaction, the chief financial officer now directly owns 13,261 shares of the company’s stock, valued at $2,877,504.39. The disclosure for this sale can be found here. Insiders own 0.30% of the company’s stock.

CME Group Trading Down 0.7 %

CME Group stock opened at $213.16 on Friday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 12 month low of $190.70 and a 12 month high of $223.80. The stock’s 50 day simple moving average is $207.86 and its two-hundred day simple moving average is $207.53. The firm has a market cap of $76.75 billion, a PE ratio of 24.25, a P/E/G ratio of 8.85 and a beta of 0.55.

CME Group (NASDAQ:CMEGet Free Report) last released its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, topping the consensus estimate of $2.53 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The business had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.53 billion. During the same quarter in the prior year, the firm posted $2.30 EPS. The business’s quarterly revenue was up 12.7% compared to the same quarter last year. Analysts anticipate that CME Group Inc. will post 9.94 earnings per share for the current year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Monday, September 9th will be given a $1.15 dividend. The ex-dividend date is Monday, September 9th. This represents a $4.60 annualized dividend and a yield of 2.16%. CME Group’s dividend payout ratio is presently 52.33%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on CME shares. Bank of America lowered CME Group from a “neutral” rating to an “underperform” rating and dropped their price target for the stock from $212.00 to $177.00 in a research note on Tuesday, September 3rd. Deutsche Bank Aktiengesellschaft boosted their price target on CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a research note on Thursday, August 15th. JPMorgan Chase & Co. boosted their price target on CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a research note on Thursday, July 25th. Barclays upped their target price on CME Group from $208.00 to $209.00 and gave the company an “equal weight” rating in a research report on Thursday, July 25th. Finally, Keefe, Bruyette & Woods upped their target price on CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research report on Thursday, July 25th. Four equities research analysts have rated the stock with a sell rating, five have given a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $209.73.

View Our Latest Stock Analysis on CME Group

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

See Also

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.